Other top stories

Experimental Alzheimer's Drug Donanemab Shows Promise in Slowing Cognitive Decline

May 4, 2023

A Reason for Hope in Rett Syndrome: New Medications, Novel Gene Therapies

May 3, 2023

Slow-Release UZEDY Gains FDA Approval, Reduces Schizophrenia Relapse by 80%

May 2, 2023

Pediatric Brain Abscess Mystery Cluster in Nevada Worries Investigators

May 1, 2023

The Weekly Mind Reader: Fast New Mood Screener

April 28, 2023

Dog Walking Linked to Surprisingly High Risk of Traumatic Brain Injury

April 27, 2023

Other stories

Qalsody is First Drug for Rare Form of ALS Approved by FDA

April 26, 2023

French Fries May Put Depression and Anxiety on the Menu

April 25, 2023

Complex PTSD Diagnosis is No Joke for Actress Kathy Griffin

April 24, 2023

New Migraine Drug May Even Prevent Treatment-Resistant Cases

April 24, 2023

Weekly Mind Reader: Opioid Abuse and Depression

April 21, 2023

Loneliness is as Deadly as Obesity and Drug Abuse, Surgeon General Says

April 20, 2023

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe